Shares of Enhabit, Inc. (NYSE:EHAB – Get Free Report) gapped up prior to trading on Thursday . The stock had previously closed at $9.51, but opened at $10.04. Enhabit shares last traded at $10.3140, with a volume of 291,501 shares.
Analysts Set New Price Targets
Several research analysts have commented on EHAB shares. UBS Group upgraded shares of Enhabit from a “neutral” rating to a “buy” rating and upped their target price for the stock from $8.50 to $12.00 in a research report on Thursday. Truist Financial set a $10.50 price objective on Enhabit and gave the stock a “hold” rating in a report on Wednesday. Wolfe Research set a $12.00 target price on Enhabit in a research note on Thursday. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enhabit in a research report on Monday, December 29th. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $11.50.
View Our Latest Stock Report on Enhabit
Enhabit Price Performance
Enhabit (NYSE:EHAB – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.12 by $0.05. The company had revenue of $263.60 million for the quarter, compared to analysts’ expectations of $267.08 million. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. As a group, research analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Enhabit
A number of institutional investors and hedge funds have recently bought and sold shares of the business. AQR Capital Management LLC boosted its position in shares of Enhabit by 115.6% during the 1st quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock valued at $1,867,000 after purchasing an additional 115,456 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Enhabit by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after purchasing an additional 1,248 shares during the last quarter. Jones Financial Companies Lllp lifted its stake in Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after purchasing an additional 8,879 shares during the last quarter. Empowered Funds LLC boosted its holdings in Enhabit by 8.4% during the first quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after buying an additional 14,690 shares in the last quarter. Finally, Acadian Asset Management LLC acquired a new position in Enhabit in the first quarter worth approximately $114,000.
Enhabit Company Profile
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Recommended Stories
- Five stocks we like better than Enhabit
- A month before the crash
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- YDES Could Be 2026’s Biotech Breakthrough
- Trump Era Reset? Why Gold Could Explode to $6,000
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
